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Abstract 1 
Little is known about who would benefit from internet-based personalised nutrition (PN) 2 
interventions. This study aimed to evaluate the characteristics of participants who achieved 3 
greatest improvements (i.e. benefit) in diet, adiposity and biomarkers following an internet-4 
based PN intervention. Adults (n=1607) from seven European countries were recruited into a 5 
6-month, randomized controlled trial (Food4Me) and randomized to receive conventional 6 
dietary advice (control) or PN advice. Information on dietary intake, adiposity, physical 7 
activity, blood biomarkers and participant characteristics was collected at baseline and month 8 
6. Benefit from the intervention was defined as ≥5% change in the primary outcome (Healthy 9 
Eating Index) and secondary outcomes (waist circumference and BMI, physical activity, 10 
sedentary time and plasma concentrations of cholesterol, carotenoids and omega-3 index) at 11 
month 6. For our primary outcome, benefit from the intervention was greater in older 12 
participants and women. Benefit was greater for individuals reporting greater self-efficacy for 13 
“sticking to healthful foods” and who “felt weird if [they] didn’t eat healthily”. Participants 14 
benefited more if they reported wanting to improve their health and wellbeing. The 15 
characteristics of individuals benefiting did not differ by other demographic, health-related, 16 
anthropometric or genotypic characteristics. Findings were similar for secondary outcomes. 17 
Older individuals, women and individuals with less healthy diets at baseline benefitted more 18 
from PN advice. The odds of benefiting did not differ by weight status, genetic risk or socio-19 
economic position. These findings have implications for the design of more effective future 20 
PN intervention studies and for tailored nutritional advice in public health and clinical 21 
settings.  22 
Key Words: Food4Me; personalised nutrition; internet-based; intervention; European; adults 23 
  24 
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INTRODUCTION 25 
Personalised nutrition (PN) approaches offer an alternative and potentially more effective 26 
strategy to improve dietary intake. (1; 2) PN interventions are tailored to key characteristics of 27 
the participant such as current diet, phenotype and genotype. (3) Although genotype-based 28 
personalised interventions designed to change risk behaviours (e.g. smoking and diet) have 29 
shown mixed results, (4) recent PN interventions have demonstrated encouraging 30 
improvements in dietary behaviours. (2; 5; 6; 7) Furthermore, internet-based interventions have 31 
the advantage of being scalable and more cost-effective than face-to-face interventions. 32 
Evidence from internet-based nutrition interventions suggests that participants who are most 33 
likely to benefit from a nutrition-related intervention are older, female and more highly 34 
educated. (8) These are also the characteristics of those who are interested in internet-based 35 
PN interventions. (9) These findings raise the possibility that other population groups may 36 
benefit less from internet-based PN interventions. However, this hypothesis is yet to be 37 
examined in a randomized controlled trial (RCT) and the characteristics of participants who 38 
benefit most from internet-based PN interventions are unknown. With the use of internet-39 
based PN interventions increasing, (10; 11) understanding the characteristics of individuals who 40 
would benefit most from such interventions is an imperative for improving the design of PN 41 
interventions that are intended to improve diet and health outcomes across the population. 42 
The Food4Me Study was a 6-month, internet-based, PN intervention conducted in seven 43 
European countries that showed that PN advice improved dietary intakes more than 44 
generalised dietary advice. (6; 10; 12; 13) The present paper examines the socio-demographic, 45 
anthropometric, physical activity-related, health-related, genotypic and behavioural 46 
characteristics of participants who benefited most from this PN intervention based on change 47 
in diet quality and adiposity following the intervention. 48 
 49 
PARTICIPANTS AND METHODS  50 
Study design 51 
The Food4Me Study (14) was a 6-month, 4-arm, internet-based RCT conducted in seven 52 
European countries, designed to compare the effects of personalised dietary and physical 53 
activity advice with generalized advice in changing dietary and lifestyle behaviours. (7; 12; 15; 16; 54 
17) Recruitment included newspapers, radio advertisements and flyers and participants could 55 
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participate in the study by registering their details on the Food4Me website. (14)  Participants 56 
and were asked via email to complete online questionnaires and to provide biological samples 57 
at baseline and after 3 and 6 months intervention. Participants could interact via email with the 58 
dietitians, nutritionists and researchers at each center during the 6-month intervention. 59 
Participants were randomized to one of four intervention arms and received either non-60 
personalised, generalized dietary advice (Control; Level 0), or one of three levels of PN based 61 
on dietary, physical activity (PA), phenotypic and genotypic data (see below). Behaviour 62 
change techniques were included in the study protocol. (12; 18) Participants were asked to 63 
complete an online food frequency questionnaire (FFQ), the Baecke PA questionnaire, (19) to 64 
wear accelerometers and to provide self-measured anthropometric information, buccal swabs 65 
and dry blood spot cards. 66 
 67 
Ethics approval and participant consent 68 
Participants (n=1607) were recruited between August 2012 and August 2013. The Research 69 
Ethics Committees at each university or research centre delivering the intervention granted 70 
ethics approval for the study. The Food4Me trial was registered as a RCT (NCT01530139) at 71 
Clinicaltrials.gov. Participants signed online consent forms. (12) 72 
 73 
Eligibility criteria 74 
Participants aged ≥18 years were included in the study. The following exclusion criteria were 75 
applied: (i) pregnant or lactating; (ii) no or limited access to the Internet; (iii) following a 76 
prescribed diet for any reason, including weight loss, in the last 3 months; (iv) diabetes, 77 
coeliac disease, Crohn’s disease, or any metabolic disease or condition altering nutritional 78 
requirements. 79 
 80 
Randomization and masking 81 
An urn randomization scheme was used to allocate individuals to each treatment arm. 82 
Participants randomized to Level 1 (L1) received personalized dietary advice based on 83 
current diet and physical activity (PA) alone, Level 2 (L2) received personalized dietary 84 
advice based on dietary, PA and phenotypic data and Level 3 (L3) received personalized 85 
dietary advice based on dietary, PA, phenotypic and genotypic data. Personalized dietary 86 
feedback was based on how intakes of specific nutrients compared with recommended 87 
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intakes, which was then translated into advice on changing intakes of food groups (fruits and 88 
vegetables, whole grain products, fish, dairy products and meat). Personalized phenotypic 89 
feedback utilized anthropometric measurements and nutrient- and metabolic-related 90 
biomarkers to derive personalized feedback and specific variants in five nutrient-responsive 91 
genes were used to provide personalized genotypic feedback. Personalized advice on PA was 92 
based on responses to the Baecke Questionnaire and accelerometer data. 93 
Participants randomized to the control group (L0) received dietary advice based on 94 
population-level healthy eating guidelines. This non-personalized dietary advice was derived 95 
from national dietary recommendations in each of the seven European countries and included 96 
generalized advice on the food groups listed above. In addition, these recommendations 97 
included a generic PA recommendation. Further details of the Food4Me PoP study are 98 
provided elsewhere (12). 99 
 100 
Personalised feedback report  101 
Participants randomized to L1, L2 and L3 received personalised feedback reports via email at 102 
baseline and at months 3 and 6 of the intervention. For those randomized to L1, L2 and L3, 103 
algorithms were used to provide participants with three specific top priority food-based 104 
dietary goals according to the individual’s intakes of foods and nutrients. (20) For participants 105 
randomized to L2 and L3, the dietary advice was also based on phenotypic data (L2) and 106 
phenotypic plus genotypic data (L3). (12) 107 
 108 
Dietary and anthropometric measures 109 
Participants completed an online FFQ to estimate usual dietary intake at baseline and at 110 
months 3 and 6 of the intervention. This FFQ was developed and validated for the Food4Me 111 
Study (21; 22) and included 157 food items consumed frequently in each of the seven 112 
recruitment countries. Intakes of foods and nutrients were computed in real time using a food 113 
composition database. (23)  114 
The Healthy Eating Index (HEI) 2010 was used to assess diet quality according to the 2010 115 
Dietary Guidelines for Americans. (24) The HEI included 12 food groups, 9 of which assessed 116 
adequacy of the diet: 1) total fruit; 2) whole fruit; 3) total vegetables; 4) greens and beans; 5) 117 
whole grains; 6) dairy; 7) total protein foods; 8) seafood and plant proteins; and 9) fatty acids. 118 
The remaining 3 groups, refined grains, sodium, and “empty calories” (i.e. energy from solid 119 
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fats, alcohol, and added sugars), included dietary components that should be consumed in 120 
moderation. Less beneficial food groups were scored such that lower intakes receive higher 121 
scores. For all components, higher scores reflected better diet quality. The scores of the 12 122 
components were summed to yield a total score with a maximum value of 100. (24) For use in 123 
sensitivity analyses, adherence to the Mediterranean diet (MD) was estimated based on a 14-124 
point criteria. Participants scored 1 point for each of the 14 criteria they met and 0 for each 125 
they did not meet; points were summed to create an overall MD score, ranging from 0-14. 126 
More details are provided elsewhere. (25; 26)  127 
Body weight (kg), height (m) and waist circumference (WC; cm) were self-measured and 128 
self-reported. Body mass index (BMI; kg/m2) was estimated from body weight and height. 129 
Self-reported measurements were validated in a sub-sample of the participants (n=140) and 130 
showed a high degree of reliability. (27)  131 
 132 
Study measures 133 
Participants self-reported smoking habits and occupations. Country of residence was treated 134 
as dummy variables, such that the odds of benefiting for participants from one country were 135 
compared to all other countries. PA level (PAL), the percentage of individuals meeting PA 136 
recommendations (>150 min moderate PA or >75 min vigorous PA or an equivalent 137 
combination of moderate and vigorous PA per week (28)) and sedentary time were estimated 138 
from triaxial accelerometers (TracmorD, Philips Consumer Lifestyle, The Netherlands) and 139 
the Baecke PA questionnaire. An online screening questionnaire collected information on 140 
meal habits, healthy eating perceptions, self-efficacy for sticking to healthy foods and 141 
motivation for participation in the study (Supplemental Table 1).  142 
Participants collected buccal cell samples at baseline using Isohelix SK-1 DNA buccal swabs 143 
and Isohelix dried-capsules. LGC Genomics (Hertfordshire, United Kingdom) extracted 144 
DNA and genotyped specific loci using TaqMan genotyping assays to provide bi-allelic 145 
scoring of single nucleotide polymorphisms: FTO (rs9939609), MTHFR (rs1801133), 146 
TCF7L2 (rs7903146), APOE(e4) (rs429358 and rs7412) and FADS1 (rs174546). Dried blood 147 
spots were collected for measurements of total cholesterol, carotenoids, n-3 fatty acid index, 148 
32 individual fatty acids and vitamin D (25-OH D2 and 25-OH D3). (29; 30; 31) 149 
 150 
Statistical analysis 151 
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All statistical analyses were performed using Stata (version 15; StataCorp, College Station, 152 
TX, USA). Data were analyzed based on intention-to-treat (ITT) of all individuals 153 
randomized into the intervention. Multiple imputation by chained equations and fully 154 
conditional specification methods, including augmentation, were used to address missing data 155 
for all outcomes. A total of 20 imputed datasets were used based on recent literature and the 156 
percent of missing data. Given that adjustment for multiple comparisons may increase the 157 
risk of type 2 error,(32) no adjustment for multiple comparisons was included. 158 
The sample size was estimated a priori using Minitab® (version 16.1.0) based on data for n-3 159 
fatty acids and glucose concentrations in European adults. To address the primary aim of the 160 
Food4Me intervention, a sample size of n=326 was planned for each of the four intervention 161 
arms. This would enable detection of 0.22 SD differences in the main outcomes with 80 % 162 
power and alpha=0.05. Assuming that the population standard deviation for n-3 fatty acid 163 
index was 1.5 units and for glucose was 1.05 mmol l−1, a total sample of n=1,280 was 164 
estimated as sufficient to detect a difference of 0.33 units for n-3 PUFA and 0.23 mmol/L 165 
glucose post-intervention. Allowing for a potential 20% drop out, recruitment was targeted at 166 
1,540 participants (220 participants per centre).(7) 167 
For our primary objective, participants randomized to L1, L2 or L3 of the intervention were 168 
identified as benefiting from the intervention if their HEI at month 6 was ≥5% better than at 169 
baseline. For our secondary outcomes, details for each definition of benefit are summarised in 170 
Supplemental Table 2. Briefly, benefit was defined as: i) ≥5% reduction in body weight 171 
and/or WC, ii) ≥5% increase in omega-3 index, iii) ≥5% increase in carotenoids, iv) ≥5% 172 
reduction in cholesterol, v) ≥5% reduction in sedentary time and vi) ≥5% increase in PA at 173 
month 6. Cut points of 5% were based on recent literature, where a change of ≥5% in body 174 
weight was identified as clinically significant. (16; 33) Logistic regression analyses, using 175 
multiple imputation estimation commands, were employed to examine associations between 176 
benefiting from the intervention (independent variable) and participant characteristics 177 
(dependent variables). Logistic regression analyses were also used to examine associations 178 
between benefiting from the intervention (independent variable) and participant 179 
characteristics (dependent variable) among participants randomized to L0 of the intervention 180 
only. An interaction effect between the characteristic and study arm (Control vs PN) was 181 
included in the model to determine whether characteristics of benefit differed between the 182 
Control and intervention groups. Analyses were adjusted for baseline age (continuous), sex, 183 
country (categorical), intervention arm (categorical) and baseline values of the outcome (i.e. 184 
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HEI, WC and body weight). PA outcomes were further adjusted for accelerometer wear time 185 
at baseline (continuous) and season (categorical). Correlations between behavioural 186 
characteristics were explored used Pearson’s correlation coefficients.  187 
As a sensitivity analysis, any impact of regression towards the mean in our estimate of 188 
change in HEI was evaluated by including a correction factor in our models according to the 189 
following equation xadj=x¯+p(x−x¯). (34) Benefit from the intervention (i.e. change in HEI 190 
and body weight/WC at month 6) was also treated as a continuous variable. To determine 191 
whether findings were robust for different measures of diet quality, benefit was defined 192 
according to change in MD score (continuous). To account for multiple comparisons, results 193 
were deemed significant at a conservative P<0.02. 194 
 195 
RESULTS 196 
A total of 1607 participants were randomized into the intervention and 1270 of these 197 
completed the intervention (Figure 1). For the purposes of this analysis, only individuals who 198 
were randomized into L1 (n=414), L2 (n=404) and L3 (n=402) were included in the main 199 
analyses (n=1220). Data were imputed for individuals who dropped out between baseline and 200 
month 6 (Supplemental Table 3 and Supplemental Table 4). 201 
The distributions of change in HEI, body weight and WC are shown in Figure 2, with the 202 
proportion of participants benefiting from the intervention by country shown in Table 1. The 203 
country with the highest proportion of participants benefiting based on the primary outcome 204 
(HEI) was Spain, whereas Greece and the Netherlands had the greatest proportion of 205 
participants with improvements in secondary outcomes (body weight and WC; Table 1). 206 
 207 
(Table 1 here) 208 
 209 
Baseline socio-demographic, anthropometric, health behaviour and biological characteristics 210 
of participants according to whether they benefited more from the PN intervention are shown 211 
in Table 2. The odds of benefiting were higher in women than in men. Older participants and 212 
participants with lower baseline HEI scores had higher odds of benefiting. The characteristics 213 
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of individuals benefiting did not differ by other health-related, anthropometric or genotypic 214 
characteristics (Table 2).  215 
 216 
(Table 2 here) 217 
 218 
Behavioural characteristics of participants benefiting from the PN intervention are shown in 219 
Table 3. The odds of a participant benefiting more from the intervention at month 6 were 220 
higher among those who reported greater self-efficacy for “sticking to healthful foods” and 221 
who “felt weird if [they] didn’t eat healthily” (HEI only), which were correlated (r 0.25, 222 
P<0.0001). Participants had a higher odds of benefiting if they were interested in improving 223 
their health and improving their wellbeing (HEI only), which were highly correlated (r 0.40, 224 
P<0.0001). The characteristics of individuals who benefited more from the intervention did 225 
not differ by other healthy eating habits or perceptions (Table 3). Baseline socio-226 
demographic, anthropometric, health-related and behavioural characteristics of participants 227 
randomized to L1, L2 and L3 of the intervention associated with benefiting from the PN 228 
intervention at month 6 according to each definition of benefit (HEI, weight loss/WC 229 
reduction, physical activity, sedentary time, cholesterol, carotenoids, omega-3 index) are 230 
shown Supplemental Table 5 and Table 6. Few participant characteristics were comparable 231 
across definitions. 232 
When stratified by PN intervention arm, odds of benefitting were higher with higher age in 233 
L2 (OR 1.05, CI: 1.01-1.08) and L3 (1.02, 1.00-1.06), with being female in L2 (3.75, 1.57-234 
8.96), with being a participant in the Netherland in L3 (3.19, 1.41-7.22). Odds were higher in 235 
participants who reported with being able to stick to healthy foods even if they had to re-think 236 
their way of nutrition (4.96, 1.55-15.81) in L1 and even if they had to try several times until it 237 
worked in L1 (22.69, 1.64-313.2) and L2 (4.96, 1.55-15.81). Odds of benefiting were also 238 
higher in participants who wanted to know what foods are best for them in L2 (5.46, 1.88-239 
15.90) and in those who reported frequently eating healthily (3.04, 1.30-7.11) in L3. Odds of 240 
benefitting were lower in participants in Germany (0.32, 0.12-0.88) in L3. No other 241 
significant differences by PN arm were observed.  242 
When the analyses were restricted to participants randomized to generalized (non-243 
personalised) dietary advice (L0), the odds of benefiting from the intervention were lower in 244 
APOE (rs429358) risk carriers (OR 0.53 [0.32, 0.91], P=0.020) but higher among individuals 245 
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reporting being in control of their own health (OR 1.71 [1.01, 2.91], P=0.047) and wanting to 246 
gain weight (OR 0.17 [0.03, 0.99], P=0.049). All other characteristics were consistent with 247 
those of participants randomized to PN. There was no interaction between participant 248 
characteristic and study arm (Control vs PN) on extent of benefit (change in HEI), with the 249 
exception of the MTHFR risk allele and participants who wanted to improve their health. HEI 250 
improved in participants randomised to PN advice who were carriers of the MTHFR risk 251 
allele (coeff 0.08, SE 0.39, P=0.043) and who wanted to improve their health (coeff 0.08, SE 252 
0.38, P=0.038) compared to those in the control arm who were not carriers of the MTHFR 253 
risk allele and did not want to improve their health, respectively. 254 
 255 
(Table 3 here) 256 
 257 
Sensitivity analyses 258 
The pattern of results was similar when change in HEI and body weight/WC at month 6 was 259 
treated as a continuous outcome (data not shown). The characteristics of participants 260 
benefiting most from the PN intervention were similar when benefit was defined using MD 261 
(data not shown) and when results for benefit (defined by HEI) were adjusted for regression 262 
towards the mean (data not shown). Comparison of benefit from the PN intervention as 263 
defined based on HEI, adiposity, omega-3 index, carotenoids, cholesterol, sedentary time and 264 
physical activity are summarised in Table 4 and Table 5.  265 
 266 
(Table 4 here) 267 
(Table 5 here) 268 
 269 
DISCUSSION 270 
This study aimed to characterize the participants benefiting most from a 6-month, internet-271 
based PN intervention. Our main findings are that older participants, women and those with 272 
less healthy diets at baseline benefited most from PN advice. The odds of benefiting did not 273 
differ by weight status, genetic risk or socio-economic position. These findings confirm the 274 
need to enhance the effectiveness of PN interventions in certain groups e.g. young men and 275 
those with unhealthier eating perceptions/motivations. These individuals may require 276 
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additional tailoring of PN advice using individual characteristics that were not investigated in 277 
this study. Nonetheless, since many participant characteristics did not affect the extent of 278 
benefit, our findings suggest that most population groups would benefit from PN advice. 279 
To the best of our knowledge, no previous studies have investigated the characteristics of 280 
individuals benefiting most from an internet-based PN intervention. Studies have shown that 281 
women, older individuals, and generally healthier individuals are more likely to participate in 282 
nutrition interventions, (35) including internet-based interventions. (36) This may be due to a 283 
greater desire to lose weight among women and older adults being more time-rich than 284 
younger adults. In addition, individuals with greater motivation to be healthy and to 285 
participate in nutrition interventions may be more knowledgeable about the benefits of 286 
healthy eating. (37) Similarly, of the 5662 individuals who expressed an interest in 287 
participating in the Food4Me Study, 65% were women. (38) Nonetheless, these individuals 288 
were broadly representative of the wider European population in terms of need to improve 289 
dietary and PA behaviours, (38) and were not skewed towards individuals who were already 290 
healthy (i.e. the worried well). In addition, in the Food4Me Study, individuals who met fewer 291 
recommendations at baseline (39) and who had lower self-perception of healthy eating habits 292 
(40) showed greatest improvement in diet following the intervention. In the present analysis, 293 
despite the odds of benefiting being higher in participants with better self-reported healthy 294 
eating perceptions and motivations, the odds of benefitting from PN advice were lower in 295 
those with higher HEI at baseline. The proportion of participants benefiting most appeared to 296 
differ by country, which suggests that there may be opportunities to tailor PN advice to 297 
different cultural norms. 298 
To a large extent, the characteristics of participants benefiting from the Control intervention 299 
were similar to those of participants benefiting most from the PN intervention. If this is a true 300 
effect, it implies that participants who benefit from PN advice are comparable to those who 301 
received general dietary advice. Moreover, it suggests that benefit extends beyond those 302 
receiving the intervention. This confirms our observed effect of the intervention on 303 
improvements in diet, where participants in the control group showed modest improvements 304 
in their diet as a result of participating in the intervention.(7) Where there were differences 305 
between treatment arms, reduced power in the Control arm could have influenced these 306 
findings.  307 
The effects of the intervention on adiposity markers (benefit from the intervention was 308 
defined as ≥5% weight loss or WC reduction), showed a somewhat different range of 309 
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participant characteristics compared with those benefiting more in respect of HEI. This may 310 
be that those who needed to lose weight were different from the general population. 311 
Moreover, the study has shown large individual variation in changes in health behaviours 312 
following a PN intervention. Such inter-individual variation is common in (dietary) 313 
intervention studies. For example, in the DIETFITS weight loss intervention study, individual 314 
body mass changes ranged over approximately 40 kg within each treatment group with some 315 
participants losing 30 kg over 12 months and others gaining 10 kg body weight.(41) Such 316 
inter-individual variation is one of the major challenges that personalised nutrition 317 
approaches aim to address. With better understanding of the participant characteristics that 318 
lead to no (or adverse) responses to interventions, there is scope to refine the personalization 319 
process and to develop intervention features that improve the target behaviours. 320 
This study had a number of strengths. The Food4Me study is the largest RCT on the 321 
effectiveness of PN advice in European adults to date, it used a rigorous design and it 322 
investigated change in health-related outcomes sustained to 6 months. We applied multiple 323 
imputation to our analyses, thus limiting bias associated with missing data and the robustness 324 
of our findings was confirmed through extensive sensitivity analyses. The pattern of results 325 
remained consistent regardless of whether benefit was defined as binary or continuous change 326 
in HEI or any of the secondary definitions and following adjustment for regression towards 327 
the mean in HEI.  328 
A limitation of our study is that data were self-measured and self-reported via the internet. 329 
Nonetheless, the accuracy of internet-based, self-reported anthropometric data have been 330 
confirmed in the Food4Me Study. (27) Dietary intakes may be subject to misreporting error, 331 
which was minimized by validation of the FFQ against a 4-day weighed food record. (22) 332 
Since 97% of our study participants were Caucasians, research in wider ethnicity groups is 333 
required to generalize our findings to other populations. Our sample is a self-selected group 334 
of individuals who may be more health-conscious than the general population. However, 335 
participants interested in joining the study were similar to the wider population of European 336 
adults, who would benefit from improved diet and PA. (42) In addition, although the cut-off 337 
points for defining benefit were based on previous research, (33) the clinical relevance of a 5% 338 
in outcome measures warrants further investigation. The present analyses requires replication 339 
in a larger study, which would provide more statistical power, particularly for testing 340 
subgroup differences in benefit. Moreover, while analyses were adjusted for appropriate 341 
confounders, we cannot discount the possibility of residual confounding. Given that analyses 342 
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were not adjusted for multiple testing, the risk of type 1 error is higher and so results should 343 
be interpreted with this in mind. Finally, although we included outcomes for 7 different 344 
health-related biomarkers, future PN interventions may wish to consider the impact of PN on 345 
the gut microbiota and on other markers of health. (43) 346 
These findings have implications for the design of more effective future PN intervention 347 
studies and tailored nutritional advice in the public health or clinical settings. Future studies 348 
should consider ways of tailoring PN advice to improve efficacy in certain population groups 349 
such as young men. Nonetheless, with many characteristics, such as weight status and 350 
occupation, being unrelated to extent of benefit in the Food4Me Study, our findings suggest 351 
that most population groups will benefit from PN advice. Further improvements in the 352 
design, delivery and efficacy of PN interventions will support integration of PN strategies 353 
into public health policies. 354 
In conclusion, older individuals, women and those with less healthy diets at baseline were 355 
likely to benefit most (i.e. improve their diet and achieve weight loss, where appropriate) 356 
from PN advice. Our findings confirm the need to enhance the effectiveness of PN 357 
interventions in certain groups e.g. young men. The odds of benefiting did not differ by 358 
weight status, genotype or socio-economic position. Since few characteristics affected the 359 
degree of benefit from the PN intervention, our findings suggest that PN approaches may be 360 
widely applicable. 361 
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Table 1. Proportion of participants (%) randomized to a PN intervention arm (L1, L2 or L3) 
benefiting from the intervention by country1 
 Total 
(n=493) 
Germany 
(n=63) 
Greece 
(n=47) 
Ireland 
(n=64) 
NL 
(n=121) 
Poland 
(n=62) 
Spain 
(n=69) 
UK  
(n=67) 
HEI 56·8 57·1 48·9 57·8 61·2 58·1 60·9 47·8 
BW and/or WC 27·0 20·6 36·1 21·9 31·4 19·4 30·4 26·9 
Physical activity 21·5 19·1 19·2 20·3 22·3 17·7 30·4 19·4 
Sedentary time 38·5 42·9 34·0 32·8 40·5 45·2 43·5 28·4 
Cholesterol 46·7 50·8 29·8 46·9 52·1 35·5 34·8 67·2 
Carotenoids 42·2 30·2 34·0 39·1 52·9 53·2 31·9 43·3 
Omega-3 index 51·9 42·9 53·2 59·4 63·6 41·9 47·8 44·8 
NL, The Netherlands; BW, Body weight (kg); WC, waist circumference (cm). 1, Benefit was defined 
as a ≥5% improvement in the outcomes from baseline to month 6. 
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Table 2. Baseline socio-demographic, anthropometric, health-related and genotypic characteristics of 
participants randomized to L1, L2 and L3 of the intervention, and multivariable adjusted odds ratio 
(95% CI) of benefiting from the PN intervention at month 6 as defined by extent of improvement in 
HEI (n=493)1 
 Total 
 
No Benefit Benefit Odds of 
benefiting2  
OR, 95% CI 
 P value 
HEI score 50·0 (9·54) 54.6 (8.07) 46.5 (9.11) 0·89 (0·86, 0·91) <0·001 
Demographics   
Age, years 43·9 (13·0) 43.0 (13.3) 44.6 (12.7) 1·03 (1·01, 1·04) <0·002 
Female, % 55·6 54.5 56.4 1·64 (1·07, 2·50) 0·023 
Occupation, %      
Professional and 
managerial 
43·6 42.3 42.9 1·09 (0·73, 1·64) 0·67 
Intermediate occupations 25·2 23.5 26.4 1·06 (0·66, 1·69) 0·82 
Routine and manual 8·32 7.98 8.57 1·04 (0·50, 2·16) 0·91 
Country, %      
Germany 12·8 12.7 12.9 0·67 (0·37, 1·21) 0·19 
Greece 9·53 11.3 8.21 0·72 (0·36, 1·42) 0·33 
Ireland 13·0 12.7 13.2 1·08 (0·59, 1·97) 0·80 
Netherlands 24·5 22.1 26.4 1·62 (1·01, 2·60) 0·044 
Poland 12·6 12.2 12.9 0·59 (0·30, 1·15) 0·12 
Spain 14·0 12.7 15.0 1·39 (0·78, 2·48) 0·26 
UK 13.6 16.4 11.4 0·85 (0·48, 1·53) 0·60 
Anthropometrics      
Body weight, kg 75·0 (14·8) 74.6 (14.3) 75.3 (15.1) 1·00 (0·98, 1·01) 0·81 
BMI, kg/m2 25·5 (4·45) 25.1 (3.89) 25.8 (4.83) 1·02 (0·97, 1·07) 0·16 
Waist circumference, cm 86·4 (12·8) 85.6 (12.4) 87.0 (13.0) 1·00 (0·98, 1·02) 0·66 
Health behaviours   
PAL 1·75 (0·18) 1.75 (0.17) 1.76 (0.18) 1·60 (0·48, 5·35) 0·45 
MVPA 45·8 (30·5) 47.1 (31.4) 44.8 (29.8) 1·00 (0·99, 1·01) 0·99 
Sedentary behaviour, min/d 758 (70·6) 756.6 (71.7) 758.8 (69.9) 1·00 (0·99, 1·01) 0·95 
Current smoker, % 8·11 7.04 8.93 1·03 (0·46, 2·31) 0·84 
Medication use, % 33·5 31.9 34.6 0·96 (0·62, 1·47) 0·84 
Genotype3   
FTO (rs9939609)  70·4 72.3 68.9 0·91 (0·59, 1·41) 0·67  
FADS1 (rs174546) 42·8 42.3 43.2 0·91 (0·60, 1·36) 0·63  
TCF7L2 (rs7903146) 48·9 49.8 48.2 0·96 (0·64, 1·44) 0·85  
APOE (rs429358) 27·4 30.1 25.4 0·95 (0·61, 1·48) 0·81  
APOE (rs7412) 12·6 13.6 11.8 0·72 (0·39, 1·32) 0·29  
MTHFR (rs1801133) 55·6 57.3 54.3 1·01 (0·67, 1·52) 0·96  
Values represent means (SD) or percentages, L=Level; L1, Participants received personalised 
nutrition advice based on their current diet; L2, Participants received personalised nutrition advice 
based on their current diet and phenotype; L3, Participants received personalised nutrition advice 
based on their current diet, phenotype and genotype; MVPA, Moderate to vigorous physical activity  
1, Multiple logistic regression was used to test for differences in characteristics between individuals 
who benefited most and the remaining participants, respectively. Analyses were adjusted for age, sex, 
country, intervention arm (except when used as the dependent variable) and baseline values of the 
outcome (i.e. HEI). PAL, MVPA and sedentary behaviour were additionally adjusted for time wearing 
the accelerometer and season. 
2, More benefit: ≥5% increase in HEI from baseline to month 6; Less benefit: <5% increase in HEI 
from baseline to month 6. 
3, probability carrier of minor allele 
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Table 3. Baseline behavioural characteristics of participants randomized to L1, L2 and L3 of the 
intervention and multivariable adjusted odds ratio (95% CI) of benefiting from the PN intervention at 
month 6 as defined by improvement in HEI (n=493)1 
 Total No 
Benefit 
Benefit Odds ratio of 
benefiting2 
(OR, 95% CI) 
P value 
Meal habits      
Often eat main meal away from home 34·3 32.9 35.4 1·08 (0·69, 1·66) 0·55 
Often skip meals and replace them with snacks 6.09 4.69 7.14 0·78 (0·33, 1·93) 0·62 
Often prepare a meal "from scratch" 30·8 28.2 32.9 0·93 (0·59, 1·45) 0·74 
Often eat hot or cooked meals 28·4 29.6 27.5 1·12 (0·71, 1·75) 0·63 
Spend a lot of time preparing a main meal 43·8 45.5 42.5 1·08 (0·72, 1·62) 0·72 
Heathy eating perceptions      
Believe I am in control of my health 71·6 70.9 72.1 1.16 (0·74, 1·82) 0·51 
Can stay healthy by taking care of myself 86·6 85.5 87.5 1·17 (0·65, 2·10) 0·61 
Efforts to improve health are a waste of time 2·43 2.35 2.50 0·71 (0·18, 2·83) 0·63 
Bored by attention paid to health and disease 1·42 0.94 1.79 1·29 (0·19, 8·87) 0·79 
There’s no use of being concerned about health 5·27 3.29 6.79 1·45 (0·53, 3·83) 0·46 
Frequently eating healthily 76·3 77.9 75.0 1·74 (1·05, 2·89) 0·033 
Eat healthily without thinking about it 44·6 47.0 42.9 1·01 (0·67, 1·51) 0·97 
Feel weird if don't eat healthily 47·7 47.4 47.9 1·67 (1·10, 2·55) 0·017 
Self-efficacy for sticking to healthful foods      
Even if I need time to develop the routines 93·1 92.0 93.9 2·35 (1·33, 4·14) 0·006 
Even if I have to try several times until it works 96·4 94.4 97.9 2·45 (1·25, 4·78) 0·009 
Even if I have to rethink my way of nutrition 85·8 83.6 87.5 1·74 (1·14, 2·46) 0·010 
Even if I do not receive support from others  87·2 87.8 86.8 1·22 (0·80, 1·87) 0·36 
Even if I have to make a detailed plan 88·4 86.9 89.6 1·30 (0·83, 2·04) 0·27 
Motivation for participating in the study      
Interested in personalised nutrition 75·7 78.4 73.6 1·19 (0·74, 1·92) 0·47 
Want to know what foods are best for him/her 79·3 76.5 81.4 1·83 (1·11, 3·02) 0·018 
Want to lose weight 43·4 39.0 46.8 1·38 (0·91, 2·10) 0·13 
Want to improve my family's health 27·6 25.8 28.9 0·98 (0·63, 1·54) 0·93 
Want to improve my health 55·8 50.7 59.6 1·52 (1·06, 2·28) 0·047 
Want to improve my wellbeing 54·8 52.6 56.4 1·31 (1·87, 1·97) 0·19 
Want to improve my sports performance 35·7 36.2 35.4 1·40 (0·90, 2·16) 0·14 
Want to prevent a future illness 60·0 56.8 62.5 1·37 (0·91, 2·07) 0·13 
Have a family history of diet-related illness 8·92 7.98 9.64 1·35 (0·67, 2·75) 0·41 
Think it is important to help academic studies 69·6 68.1 70.7 1·36 (0·88, 2·12) 0·17 
Curious to find out what happens in PN studies 47·1 45.1 48.6 1·24 (0·83, 1·86) 0·30 
Values represent percentages. L=Level; L1, Participants received personalised nutrition advice based 
on their current diet; L2, Participants received personalised nutrition advice based on their current diet 
and phenotype; L3, Participants received personalised nutrition advice based on their current diet, 
phenotype and genotype;  
1, Multiple logistic regression was used to test for differences in characteristics between individuals 
who benefited most and the remaining participants, respectively. Analyses were adjusted for age, sex, 
country, intervention arm (except when used as the dependent variable) and baseline values of the 
outcome (i.e. HEI). PAL, MVPA and sedentary behaviour were additionally adjusted for time wearing 
the accelerometer and season. For the purposes of this table, phrasing of characteristics has been 
paraphrased from the original questionnaire (see Supplemental Table 1) 
2, Benefit: ≥5% increase in HEI from baseline to month 6; No benefit: <5% increase in HEI from 
baseline to month 6.  
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Figure 1. Consort diagram of participants included in the Food4Me study 
Figure 2. Distribution of change among Food4Me participants in a) Healthy Eating Index 
(HEI); b) waist circumference (WC); and c) body weight (BW). Participants achieving a 
greater than 5% improvement in HEI and BW/WC at month 6 are in light grey. 
Supplemental Table 1. Screening questionnaire on dietary habits and reasons for interest in 
the study 
Supplemental Table 2. Definitions for benefit from the intervention for secondary outcomes  
Supplemental Table 3. Summary of missing data for variables at baseline 
Supplemental Table 4. Baseline socio-demographic, anthropometric, health behaviour-related 
and genotypic characteristics of all participants randomized to L1, L2 and L3 of the 
intervention in imputed dataset and complete case analysis 
Supplemental Table 5. Baseline socio-demographic, anthropometric, health-related and 
genotypic characteristics of participants randomized to L1, L2 and L3 of the intervention 
associated with benefiting from the PN intervention at month 6 according to each definition 
of benefit 1 ✓=significant benefit, X=significant non-benefit 
 
Supplemental Table 6. Baseline behavioural characteristics of participants randomized to L1, 
L2 and L3 of the intervention benefiting from the PN intervention at month 6 according to 
each definition of benefit 1 ✓=significant benefit, X=significant non-benefit 
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Figure 1 
Level 0 “Control” 
 n=387 
Level 1 
 n=414 
Level 2 
 n=404 
Level 3 
 n=402 
Completed the study 
 n=312  
Completed the study 
 n=325 
Completed the study 
 n=321 
Dropouts 
immediately after 
randomization 
 n=27 
 
Dropouts 
immediately after 
randomization 
 n=41 
 
Dropouts 
immediately after 
randomization 
 n=28 
 
Dropouts 
immediately after 
randomization 
 n=31 
 
Lost to follow up 
 n=48 
Lost to follow up 
 n=61 
Lost to follow up 
 n=53 
Lost to follow up 
 n=50 
Completed the study 
 n=312  
Participants who registered online 
for the Food4Me Study 
n=5562 
Participants randomised into one 
of the 4 arms on the intervention 
n=1607 
Excluded, n=1631* 
- Not willing to share 
information, n=35 
- Incomplete 2nd screening 
questionnaire, n =562 
- Pregnant, n=181 
- Therapeutic diet, n=350 
- Food allergy/intolerance, n=658 
- No Internet, n=28 
 
2nd Screening questionnaire 
n=3811 
1st Screening questionnaire 
n=5442 
Excluded, n=120 
- Incomplete 1st screening 
questionnaire 
Excluded, n= 1029* 
- Second consent not given, n=238 
- Incomplete/under-reported food 
frequency questionnaire, n=535 
- Food allergy/intolerance, n=93 
- Therapeutic diet, n=199 
- Limited physical activity n=252 
Excluded, n=1175 
- Study design and sample size 
estimation required n=1607 only 
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Supplemental Table 1. Screening questionnaire on dietary habits and reasons for interest in the study 
 
Question Response options Aggregated response 
How often do you eat your main meal away from 
home? 
Never or up to once/ 
month  
Two to three times/ 
month 
Once per week 
Twice or more/ week 
Rarely 
Often 
How many hot or cooked meals do you normally eat 
per day? 
How often do you prepare a meal "from scratch"? Every day 
4-6 times per week 
1-3 times per week 
(Almost) never 
Often 
Rarely 
 
Do you skip meals and replace them with snacks? Often 
Rarely 
How much time on average do you spend preparing a 
main meal? 
Less than 10 min 
10-20 min 
20-30 min 
Up to an hour 
Over an hour 
Less than 30 min 
More than 30 min 
I can be as healthy as I want to be Completely disagree 
Disagree 
Neither disagree nor 
agree 
Agree 
Completely agree 
Disagree 
Neither disagree nor 
agree 
 Agree  
Note that the option 
'Neither disagree nor 
agree' was excluded in 
the data analysis 
I am in control of my health 
I can pretty much stay healthy by taking care of myself 
Efforts to improve your health are a waste of time 
I am bored by all the attention that is paid to health and 
disease prevention 
What's the use of concerning yourself about your 
health - you'll only worry yourself to death 
Eating healthily is something I do frequently 
I eat healthily without having to consciously think 
about it 
I feel weird if I don't eat healthily 
Eating healthily is something he/she does without 
having to think about doing 
I'm interested in personalised nutrition No 
Yes 
No 
Yes I want to know what foods are best for me 
I want to lose weight 
I want to gain weight 
I want to improve my family's health 
I want to improve my health 
I want to improve my wellbeing 
I want to improve my sports performance 
I want to prevent a future illness 
I have a family history of diet-related illness 
I think it is important to help academic studies 
I am curious to find out what happens in these studies 
I can manage to stick to healthful foods: even if I need 
a long time to develop the necessary routines 
Very uncertain 
Rather uncertain 
Rather certain 
Very certain 
 Not certain 
Certain 
 I can manage to stick to healthful foods: even if I have 
to try several times until it works 
I can manage to stick to healthful foods: even if I have 
to rethink my entire way of nutrition 
I can manage to stick to healthful foods: even if I do 
not receive a great deal of support from others when 
making my first attempts 
I can manage to stick to healthful foods: even if I have 
to make a detailed plan 
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Supplemental Table 2. Definitions for benefit from the intervention for secondary outcomes  
Outcome Definition 
Body weight and/or WC ≥5% reduction in body weight and/or WC among individuals 
were advised to lose weight (i.e. if they had a BMI >25 kg/m2 
or a WC >88cm in women and >102 in men) 
Omega-3 index ≥5% increase in omega-3 index among individuals who were 
advised to increase their omega-3 intake (i.e. who had a blood 
cholesterol concentration <4% and/or dietary intake <0.2% of 
total energy and for whom omega-3 was a top 3 priority target) 
Carotenoids ≥5% increase in carotenoids among individuals who were 
advised to increase their carotenoid intake (i.e. who had a blood 
carotenoid concentration <1.3uM and for whom carotenoids 
was a top 3 priority target) 
Cholesterol ≥5% reduction in cholesterol among individuals who were 
advised to improve their cholesterol concentrations (i.e. who 
had a blood cholesterol concentration >8mmol/L and for whom 
cholesterol was a top 3 priority target) 
Sedentary time ≥5% reduction in sedentary time among individuals who were 
advised to increase their PA (i.e. who had a PAL <1.5 or a total 
activity index <5.5) 
Physical Activity (PA) ≥5% increase in PA among individuals who were advised to 
increase their PA (i.e. who had a PAL <1.5 or a total activity 
index <5.5) 
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Supplemental Table 3. Summary of missing data for variables at baseline1 
Variable Number of participants 
imputed 
Percentage of imputed 
relative to baseline 
Delta HEI at month 6 337 21·0 
Delta MD at month 6 337 21·0 
HEI 127 7·90 
MD 127 7·90 
PAL 320 19·9 
Sedentary time 320 19·9 
Moderate to vigorous physical activity 320 19·9 
Wear time of accelerometer  320 19·9 
Season accelerometer worn 23 1·43 
Professional occupation 129 8·03 
Intermediate occupation 129 8·03 
Manual occupation 129 8·03 
Body weight 127 7·90 
Waist circumference 131 8·15 
BMI 127 7·90 
FTO (rs9939609)                                   125 7·78 
FADS1 (rs174546) 125 7·78 
TCF7L2 (rs7903146) 128 7·97 
APOE (rs429358) 125 7·78 
APOE (rs7412) 131 8·15 
MTHFR (rs1801133) 125 7·78 
Self-efficacy for sticking to healthful foods:   
Even if I need time to develop the routines 44 2·74 
Even if I have to try several times until it works 44 2·74 
Even if I have to rethink my entire way of nutrition 44 2·74 
Even if I do not receive support from others  44 2·74 
Even if I have to make a detailed plan 44 2·74 
BMI, Body Mass Index, HEI, Healthy Eating Index, MD, Mediterranean Diet score, PAL, Physical Activity 
Level 
1, All data refer to baseline with the exception of “Delta HEI at month 6” and “Delta MD at month 6”  
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Supplemental Table 4. Baseline socio-demographic, anthropometric, health behaviour-related and genotypic 
characteristics of all participants randomized to L1, L2 and L3 of the intervention in imputed dataset and 
complete case analysis 
 Imputed dataset1 
(n=1220) 
Complete case2 
(n=930) 
HEI score 49·1 (0·30) 49·3 (9·77) 
Demographics   
Age, years 39·7 (0·37) 41·1 (12·9) 
Female, % 59·3 (1·41) 56·7 
Occupation, probability   
Professional and managerial 39·3 (1·46) 40·3 
Intermediate occupations 26·6 (1·33) 27·0 
Routine and manual 9·89 (0·89) 9·25 
Country, %   
Germany 13·8 (0·99) 14·3 
Greece 14·5 (1·01) 14·6 
Ireland 13·8 (1·00) 12·6 
Netherlands 13·8 (1·00) 17·4 
Poland 13·8 (1·00) 13·1 
Spain 13·9 (1·00) 14·7 
The UK 14·6 (1·01) 13·2 
Anthropometrics   
Body weight, kg 74·6 (0·48) 75·0 (15·8) 
BMI, kg/m2 25·5 (0·15) 25·5 (4·84) 
Waist circumference, cm 85·5 (0·40) 86·1 (13·7) 
Health behaviours  
PAL 1·74 (0·57) 1·74 (0·17) 
MVPA 46·2 (0·99) 45·5 (29·7) 
Sedentary behaviour, min/d 744 (2·47) 747 (74·6) 
Current smoker, % 11·6 (0·92) 11·1 
Medication use, % 29·5 (1·31) 30·3 
Genotype, % carrier of minor allele  
FTO (rs9939609)  67·7 (1·41) 68·0 
FADS1 (rs174546) 42·9 (1·48) 43·9 
TCF7L2 (rs7903146) 47·5 (1·49) 47·4 
APOE (rs429358) 25·6 (1·29) 26·3 
APOE (rs7412) 12·6 (0·99) 12·4 
MTHFR (rs1801133) 54·4 (1·47) 55·3 
L=Level; L1, Participants received personalised nutrition advice based on their current diet; L2, Participants 
received personalised nutrition advice based on their current diet and phenotype; L3, Participants received 
personalised nutrition advice based on their current diet, phenotype and genotype; MVPA, Moderate to vigorous 
physical activity 
1, Values have been imputed using multiple imputation. Values represent means (SE) or probabilities (SE) 
2, Values represent means (SD) or percentage 
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Supplemental Table 5. Baseline socio-demographic, anthropometric, health-related and genotypic 
characteristics of participants randomized to L1, L2 and L3 of the intervention associated with benefiting from 
the PN intervention at month 6 according to each definition of benefit 1 ✓=significant benefit, X=significant 
non-benefit 
 HEI 
(n=493) 
Weight 
loss/ WC 
reduction 
(n=231) 
Physical 
activity 
(n=333) 
Sedentary 
time 
(n=333) 
Cholesterol 
(n=36) 
Carotenoids 
(n=140) 
Omega-
3 index 
(n=88) 
HEI score        
Demographics   X     
Age, years ✓       
Female, probability ✓   ✓    
Occupation, 
probability 
       
Professional and 
managerial 
   X    
Intermediate 
occupations 
  ✓     
Routine and manual        
Country, 
probability 
       
Germany        
Greece      X  
Ireland        
Netherlands ✓       
Poland        
Spain   ✓     
UK        
Anthropometrics        
Body weight, kg        
BMI, kg/m2        
Waist 
circumference, cm 
 ✓   X   
Health behaviours        
PAL       ✓ 
MVPA       ✓ 
Sedentary 
behaviour, min/d 
      X 
Current smoker, 
probability 
       
Medication use, 
probability 
       
Genotype, 
probability carrier 
of minor allele 
       
FTO (rs9939609)         
FADS1 (rs174546)        
TCF7L2 
(rs7903146) 
       
APOE (rs429358)       ✓ 
APOE (rs7412)  ✓    X  
MTHFR 
(rs1801133) 
       
Supplemental Table 6. Baseline behavioural characteristics of participants randomized to L1, L2 and L3 of the 
intervention benefiting from the PN intervention at month 6 according to each definition of benefit 1 
✓=significant benefit, X=significant non-benefit1 
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 HEI 
(n=493) 
Physical 
activity 
(n=333) 
Sedentary 
time 
(n=333) 
Carotenoids 
(n=140) 
Omega-3 
index 
(n=88) 
Meal habits      
Often eat main meal away from 
home 
     
Often skip meals and replace 
them with snacks 
  X  X 
Often prepare a meal "from 
scratch" 
 ✓    
Often eat hot or cooked meals  ✓    
Spend a lot of time preparing a 
main meal 
     
Heathy eating perceptions      
Believe I am in control of my 
health 
     
Can stay healthy by taking care 
of myself 
 ✓ ✓   
Efforts to improve health are a 
waste of time 
     
Bored by attention paid to health 
and disease 
     
There’s no use of being 
concerned about health 
     
Frequently eating healthily ✓     
Eat healthily without thinking 
about it 
    X 
Feel weird if don't eat healthily ✓     
Self-efficacy for sticking to 
healthful foods 
     
Even if I need time to develop 
the routines 
✓     
Even if I have to try several 
times until it works 
✓     
Even if I have to rethink my way 
of nutrition 
✓     
Even if I do not receive support 
from others  
     
Even if I have to make a detailed 
plan 
     
Motivation for participating in 
the study 
     
Interested in personalised 
nutrition 
     
Want to know what foods are 
best for him/her 
✓     
Want to lose weight     X 
Want to improve my family's 
health 
     
Want to improve my health ✓     
Want to improve my wellbeing      
Want to improve my sports 
performance 
     
Want to prevent a future illness      
Have a family history of diet-
related illness 
     
Think it is important to help 
academic studies 
   ✓  
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Curious to find out what 
happens in PN studies 
     
1, Columns for Weight loss/ WC reduction (n=231) and Cholesterol (n=36) were removed due to a lack of 
significant result 
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 4-5 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 6 
2b Specific objectives or hypotheses 6 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 7 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons NA 
Participants 4a Eligibility criteria for participants 8 
4b Settings and locations where the data were collected 7-8 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
8-10 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
11-12 
6b Any changes to trial outcomes after the trial commenced, with reasons NA 
Sample size 7a How sample size was determined NA 
7b When applicable, explanation of any interim analyses and stopping guidelines NA 
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Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 8 
8b Type of randomisation; details of any restriction (such as blocking and block size) 8 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
NA 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
8 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
NA 
11b If relevant, description of the similarity of interventions NA 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 11-12 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 11-12 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1 
Recruitment 14a Dates defining the periods of recruitment and follow-up 7-8 
14b Why the trial ended or was stopped NA 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 23-24 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
12 
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Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
25-27 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended NA 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
14 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) NA 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 16-17 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 17 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 14-16 
Other information 
 
Registration 23 Registration number and name of trial registry 3 
Protocol 24 Where the full trial protocol can be accessed, if available 3 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 18 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
 
